Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes - PubMed (original) (raw)
Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes
J N Clore et al. Diabetes. 2000 Jun.
Abstract
Despite the effects of hyperinsulinemia and hyperglycemia, 2 factors known to inhibit endogenous glucose production (EGP) in nondiabetic subjects, increased EGP is a consistent feature of type 2 diabetes. Recent studies have suggested that increased glucose-6-phosphatase (G6Pase) and/or decreased glucokinase (GK) may explain the increase in EGP. However, no studies to date have clearly established this relationship in type 2 diabetes. The present studies were designed to determine rates of EGP and the activities of G6Pase and GK in obese patients scheduled for gastric bypass surgery. The study group consisted of 14 obese nondiabetic subjects and 13 patients with type 2 diabetes (BMI 53.7 +/- 2.4 vs. 50.1 +/- 1.6 kg/m2). Rates of EGP were determined after an overnight fast with a 4-h infusion of [6,6]-D-glucose, and they were significantly higher in the type 2 diabetic patients (85.9 +/- 10.0 vs. 137.8 +/- 14.4 mg x m(-2) x min(-1), P < 0.001) despite greater plasma glucose (5.1 +/- 0.1 vs. 12.0 +/- 1.1 mmol/l) and similar insulin concentrations (130.8 +/- 19.8 vs. 112.8 +/- 16.2 pmol/l, NS). Moreover, resistance to insulin-induced suppression of EGP was observed in the patients with type 2 diabetes when insulin concentrations were increased from approximately 120 to 180 pmol/l. Hepatic G6Pase activity determined from freshly isolated microsomes was significantly increased in the type 2 diabetic patients compared with the obese control subjects (0.16 +/- 0.02 vs. 0.09 +/- 0.01 micromol x min(-1) x mg(-1) protein, P < 0.02), whereas levels of GK were decreased (1.20 +/- 0.16 vs. 2.01 +/- 0.01 micromol x min(-1) x mg(-1) protein, P < 0.01). Net flux through G6Pase was significantly increased in type 2 diabetic patients (P < 0.01). We conclude that increased EGP is mediated in part by increased G6Pase flux in type 2 diabetes.
Similar articles
- The glucose-6-phosphatase/glucokinase ratio in the liver of obese-diabetic subjects.
Belfiore F, Romeo F, Iannello S, Salamone C. Belfiore F, et al. Biochem Med Metab Biol. 1989 Feb;41(1):77-80. doi: 10.1016/0885-4505(89)90011-x. Biochem Med Metab Biol. 1989. PMID: 2540781 - A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage of diabetes.
Shin JS, Torres TP, Catlin RL, Donahue EP, Shiota M. Shin JS, et al. Am J Physiol Regul Integr Comp Physiol. 2007 Apr;292(4):R1381-90. doi: 10.1152/ajpregu.00260.2006. Epub 2007 Jan 4. Am J Physiol Regul Integr Comp Physiol. 2007. PMID: 17204595 - Fat-induced liver insulin resistance.
Shah P, Basu A, Rizza R. Shah P, et al. Curr Diab Rep. 2003 Jun;3(3):214-8. doi: 10.1007/s11892-003-0066-1. Curr Diab Rep. 2003. PMID: 12762968 Review. - Tracer-determined glucose fluxes in health and type 2 diabetes: basal conditions.
Radziuk J, Pye S. Radziuk J, et al. Best Pract Res Clin Endocrinol Metab. 2003 Sep;17(3):323-42. doi: 10.1016/s1521-690x(03)00038-1. Best Pract Res Clin Endocrinol Metab. 2003. PMID: 12962689 Review.
Cited by
- Edible mushroom (Pleurotus cornucopiae) extract vs. glibenclamide on alloxan induced diabetes: sub-acute in vivo study of Nrf2 expression and renal toxicity.
Uzomba CG, Ezemagu UK, Ofoegbu MS, Lydia N, Goodness E, Emelike C, Obinna U, Nwafor AJ, Mbajiorgu EF. Uzomba CG, et al. Anat Cell Biol. 2024 Sep 30;57(3):446-458. doi: 10.5115/acb.24.054. Epub 2024 Jul 5. Anat Cell Biol. 2024. PMID: 38972671 Free PMC article. - The role of adipose tissue dysfunction in hepatic insulin resistance and T2D.
Sancar G, Birkenfeld AL. Sancar G, et al. J Endocrinol. 2024 Aug 2;262(3):e240115. doi: 10.1530/JOE-24-0115. Print 2024 Sep 1. J Endocrinol. 2024. PMID: 38967989 Free PMC article. Review. - Resveratrol attenuates high glucose-induced inflammation and improves glucose metabolism in HepG2 cells.
Tshivhase AM, Matsha T, Raghubeer S. Tshivhase AM, et al. Sci Rep. 2024 Jan 11;14(1):1106. doi: 10.1038/s41598-023-50084-6. Sci Rep. 2024. PMID: 38212345 Free PMC article. - A plasma membrane-associated glycolytic metabolon is functionally coupled to KATP channels in pancreatic α and β cells from humans and mice.
Ho T, Potapenko E, Davis DB, Merrins MJ. Ho T, et al. Cell Rep. 2023 Apr 25;42(4):112394. doi: 10.1016/j.celrep.2023.112394. Epub 2023 Apr 13. Cell Rep. 2023. PMID: 37058408 Free PMC article. - A caveolin-1 dependent glucose-6-phosphatase trafficking contributes to hepatic glucose production.
Gautier-Stein A, Chilloux J, Soty M, Thorens B, Place C, Zitoun C, Duchampt A, Da Costa L, Rajas F, Lamaze C, Mithieux G. Gautier-Stein A, et al. Mol Metab. 2023 Apr;70:101700. doi: 10.1016/j.molmet.2023.101700. Epub 2023 Mar 2. Mol Metab. 2023. PMID: 36870604 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous